Today we are glad to announce that Neuro-MS/D (also CloudTMS) transcranial stimulator and DCC-03-125-C coil are cleared by FDA for the treatment of adult patients diagnosed with obsessive-compulsive disorder (OCD).
Nowadays, both pharmacological and non-pharmacological options are used to treat the obsessive–compulsive disorder. Most often a patient is offered either pharmacological or the combined treatment consisting of medication and psychotherapy, which really works, but, unfortunately, not for everyone. If the patient does not respond to medication or can not tolerate the side effects of medication, rTMS therapy becomes an alternative.
Learn more about Neurosoft TMS solutions here.
